
Cancer Genetics India Private Limited
About Cancer Genetics India Private Limited
Data last updated:
Cancer Genetics India Private Limited was a foreign private limited company based in Visakhapatnam, Andhra Pradesh, India, operated as a subsidiary of Cancer Genetics Inc. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 02 July 2014.
The company was registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2014FTC094746.
The company had an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.54 Cr. It was led by directors including Panna Lal Sharma and Raju S K Chaganti.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Plot No: 65 66 & 67 Jawaharlal Nehru Pharma City Thanam Parawada, Visakhapatnam, Andhra Pradesh, India – 531019.
Company details
Contact details
Cancer Genetics India Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No: 65 66 & 67 Jawaharlal Nehru Pharma City Thanam Parawada, Visakhapatnam, Andhra Pradesh, India – 531019
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Cancer Genetics India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cancer Genetics India Private Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cancer Genetics India Private Limited, buy the company report.
Board of directors of Cancer Genetics India Private Limited
Cancer Genetics India has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Panna Lal Sharma | Director | 02 Jul 2014 | 12 Years 4 Months | As last reported |
| Nagabhushana Sastry Modali | Additional Director | 16 Feb 2017 | 9 Years 8 Months | As last reported |
| Raju S K Chaganti | Director | 08 Aug 2014 | 12 Years 3 Months | As last reported |
| Bobba Venkatadri | Additional Director | 07 Oct 2014 | 12 Years 1 Months | As last reported |
Auditor
Cancer Genetics India Private Limited is audited by Suresh Surana & Associates LLP for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suresh Surana & Associates LLP | FY 2016 | 121750W/W1 |
Shareholding
The shareholding of Cancer Genetics India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cancer Genetics India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cancer Genetics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cancer Genetics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Cancer Genetics India has 1 associated company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Cancer Genetics India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cancer Genetics India Private Limited has 6 board changes on record since 2014: 4 appointments and 2 cessations. The latest: Nagabhushana Sastry Modali was appointed as Additional Director on 16 Feb 2017.
Frequently asked questions
Cancer Genetics India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Cancer Genetics India was a foreign private limited company based in Visakhapatnam, Andhra Pradesh, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 02 July 2014 and is registered under CIN U24100AP2014FTC094746. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Cancer Genetics India was incorporated on 02 July 2014. It is registered with the Registrar of Companies, Vijayawada.
Cancer Genetics India had 4 directors:
- Panna Lal Sharma - Director
- Nagabhushana Sastry Modali - Additional Director
- Raju S K Chaganti - Director
- Bobba Venkatadri - Additional Director
The CIN (Corporate Identification Number) of Cancer Genetics India is U24100AP2014FTC094746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cancer Genetics India is at Plot No: 65 66 & 67 Jawaharlal Nehru Pharma City Thanam Parawada, Visakhapatnam, Andhra Pradesh, India – 531019.
The latest financial statements of Cancer Genetics India on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
Cancer Genetics India operated in the healthcare industry, in the diagnostic centers and pathology labs segment.
Nagabhushana Sastry Modali was appointed as Additional Director on 16 Feb 2017. Raviprasad Pisupati ceased to be Director on 01 Jan 2017. Bobba Venkatadri was appointed as Additional Director on 07 Oct 2014. Cancer Genetics India has 6 board changes on record in total.
Cancer Genetics India can be reached at its registered office: Plot No: 65 66 & 67 Jawaharlal Nehru Pharma City Thanam Parawada, Visakhapatnam, Andhra Pradesh, India – 531019.

